Delcath Systems (NSDQ:DCTH) and a group of investors made an end run around the company’s shareholders with a deal that paves the way for the reverse split that stockowners have twice shot down.
“Together with our Board of Directors, we are taking these actions in the best interests of all shareholders. Regaining access to equity capital will allow us to continue investing in our Clinical Development Program and our commercial efforts in Europe,” president & CEO Jennifer Simpson wrote in a letter to Delcath’s shareholders.
Get the full story at our sister site, Drug Delivery Business News.
The post Delcath deal with investors raises $500k, clears path for reverse split appeared first on MassDevice.
from MassDevice http://ift.tt/2wLvzBX
Cap comentari:
Publica un comentari a l'entrada